Progress Toward Clinical Application of the Nitric Oxide-Releasing Diazeniumdiolates

Annual Review of Pharmacology and Toxicology

Volumn 43, Issue , 2003, Pages 585-607

  Keefer, Larry K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Impotence; Respiratory distress; Restenosis; Thromboresistance; Vasospasm

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; DIAZENIUMDIOLATE DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE DONOR; OLEIC ACID; PHOSPHODIESTERASE INHIBITOR; POLYMER; SILDENAFIL; SPERMINE; UNCLASSIFIED DRUG; AZO COMPOUND; DIAZENIUMDIOLATE;

BIOSENSOR; BLOOD VESSEL GRAFT; COVALENT BOND; DEVICE; DRUG CLEARANCE; DRUG DESIGN; DRUG HALF LIFE; DRUG MECHANISM; DRUG STRUCTURE; ERECTILE DYSFUNCTION; EXTRACORPOREAL OXYGENATION; HUMAN; HYDROLYSIS; HYPOTENSION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OXIDATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REDUCTION; RESPIRATORY DISTRESS SYNDROME; RESTENOSIS; REVIEW; THROMBOGENICITY; VASOSPASM; CHEMISTRY; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

AZO COMPOUNDS; DRUG DESIGN; HUMANS; NITRIC OXIDE; NITRIC OXIDE DONORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0012707876     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.43.100901.135831     Document Type: Review

References (39)

1. Djerassi C. 1998. NO. Athens: Univ. Georgia Press
2. Davies KM, Wink DA, Saavedra JE, Keefer LK. 2001. Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution. J. Am. Chem. Soc. 123:5473-81
3. Gow AJ, Thom SR, Brass C, Ischiropoulos H. 1997. Electrochemical detection of nitric oxide in biological systems. Microchem. J. 56:146-54
4. Saavedra JE, Booth MN, Hrabie JA, Davies KM, Keefer LK. 1999. Piperazine as a linker for incorporating the nitric oxide-releasing diazeniumdiolate group into other biomedically relevant functional molecules. J. Org. Chem. 64:5124-31
5. Saavedra JE, Shami PJ, Wang LY, Davies KM, Booth MN, et al. 2000. Esterasesensitive nitric oxide donors of the diazeniumdiolate family. In vitro antileukemic activity. J. Med. Chem. 43:261-69
6. George SE. 1999. Nitric oxide and restenosis: opportunities for therapeutic intervention. Coronary Artery Dis. 10:295-300
7. Kaul S, Cercek B, Rengstrom J, Xu X-P, Molloy MD, et al. 2000. Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappa B. J. Am. Coll. Cardiol. 35:493-501
8. Baek SH, Hrabie JA, Keefer LK, Hou D, Fineberg N, et al. 2002. Augmentation of intrapericardial nitric oxide level by a prolonged-release nitric oxide donor reduces luminal narrowing after porcine coronary angioplasty. Circulation 105:2779-84
9. Fitzhugh AJ, Cheng P, Tedeschi G, Saavedra JE, Hendricks M, et al. 2000. Preparation of nitric oxide-releasing metal surfaces. Nitric Oxide 4 (Abstr. 151):255
10. Vural KM, Bayazit M. 2001. Nitric oxide: implications for vascular and endovascular surgery. Eur. J. Endovasc. Surg. 22:285-93
11. - group. J. Med. Chem. 39:1148-56
12. Muntean W. 1999. Coagulation and anticoagulation in extracorporeal membrane oxygenation. Artif. Organs 23:979-83
13. Annich GM, Meinhardt JP, Mowery KA, Ashton BA, Merz SI, et al. 2000. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers. Crit. Care Med. 28:915-20
14. Zhang H, Annich GM, Miskulin J, Osterholzer K, Merz SI, et al. 2002. Nitric oxide releasing silicone rubbers with improved blood compatibility: preparation, characterization, and in vivo evaluation. Biomaterials 23:1485-94
15. Pluta RM, Oldfield EH, Boock RJ. 1997. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J. Neurosurg. 87:746-51
16. Qureshi AI, Suarez JI, Bhardwaj A, Yahia AM, Tamargo RJ, Ulatowski JA. 2000. Early predictors of outcome in patients receiving hypervolemic and hypertensive therapy for symptomatic vasospasm after subarachnoid hemorrhage. Crit. Care Med. 28:824-29
17. Wolf EW, Banerjee A, Soble-Smith J, Dohan FC Jr, White RP, Robertson JT. 1998. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. J. Neurosurg. 89:279-88
18. Tierney TS, Clatterbuck RE, Lawson C, Thai Q-A, Rhines LD, Tamargo RJ. 2001. Prevention and reversal of experimental posthemorrhagic vasospasm by the periadventitial administration of nitric oxide from a controlled-release polymer. Neurosurgery 49:945-53
19. Golombek SG. 2000. The use of inhaled nitric oxide in newborn medicine. Heart Dis. 2:342-47
20. Hampl V, Tristani-Firouzi M, Hutsell TC, Archer SL. 1996. Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension. Cardiovasc. Res. 31:55-62
21. Jacobs BR, Brilli RJ, Ballard ET, Passerini DJ, Smith DJ. 1998. Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury. Am. J. Respir. Crit. Care Med. 158:1536-42
22. Jacobs BR, Smith DJ, Zingarelli B, Passerini DJ, Ballard ET, Brilli RJ, 2000, Soluble nitric oxide donor and surfactant improve oxygenation and pulmonary hypertension in porcine lung injury. Nitric Oxide 4:412-22
23. Brilli RJ, Krafte-Jacobs B, Smith DJ, Roselle D, Passerini D, et al. 1997. Intratracheal instillation of a novel NO/nucleophile adduct selectively reduces pulmonary hypertension. J. Appl. Physiol. 83:1968-75
24. Brilli RJ, Krafte-Jacobs B, Smith DJ, Passerini D, Moore L, Ballard ET. 1998. Aerosolization of novel nitric oxide donors selectively reduce pulmonary hypertension. Crit. Care Med. 26:1390-96
25. Adrie C, Ichinose F, Holzmann A, Keefer L, Hurford WE, Zapol WM. 1998. Pulmonary vasodilation by nitric oxide gas and prodrug aerosols in acute pulmonary hypertension. J. Appl. Physiol. 84:435-41
26. Lam C-F, Sviri S, Ilett KF, van Heerden PV. 2002. Inhaled diazeniumdiolates (NONOates) as selective pulmonary vasodilators. Expert Opin. Investig. Drugs 11:897-909
27. Lam C-F, van Heerden PV, Sviri S, Roberts BL, Ilett KF. 2002. The effects of inhalation of a novel nitric oxide donor, DETA/NO, in a patient with severe hypoxaemia due to acute respiratory distress syndrome. Anaesth. Intensive Care 30:472-76
28. Champion HC, Bivalacqua TJ, Wang R, Kadowitz PJ, Keefer LK, et al. 1999. Induction of penile erection by intracavernosal and transurethral administration of novel nitric oxide donors in the cat. J. Urol. 161:2013-19
29. Saavedra JE, Billiar TR, Williams DL, Kim Y-M, Watkins SC, Keefer LK. 1997. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-α-induced apoptosis and toxicity in the liver. J. Med. Chem. 40:1947-54
30. 2-Vinyl 1-(pyrrolidin-1-yl) diazen-1-ium-1,2-diolate protection against D-galactos amine/endotoxin-induced hepatotoxicity in mice: genomic analysis using microarrays. J. Pharmacol. Exp. Ther. 300:18-25
31. Ricciardi R, Foley DP, Quarfordt SH, Saavedra JE, Keefer LK, et al. 2001. V-PYRRO/NO: an hepato-selective nitric oxide donor improves porcine liver hemodynamics and function after ischemia reperfusion. Transplantation 71:193-98
32. Liu J, Li C, Waalkes MP, Clark J, Myers P, et al. 2002. The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced hepatotoxicity in mice. Hepatology. Submitted
33. Saavedra JE, Southan GJ, Davies KM, Lundell A, Markou C, et al. 1996. Localizing antithrombotic and vasodilatory activity with anovel, ultrafast nitric oxide donor. J. Med. Chem. 39:4361-65
34. Wu X, Tang X, Xian M, Wang PG. 2001. Glycosylated diazeniumdiolates: a novel class of enzyme-activated nitric oxide donors. Tetrahedron Lett. 42:3779-82
35. Alston TA, Bright HJ. 1982. Enzymatic release of nitric oxide from L-alanosine, an antineoplastic antibiotic. Biochem. Biophys. Res. Commun. 105:560-66
36. Alston TA, Porter DJT, Bright HJ. 1985. Generation of nitric oxide by enzymatic oxidation of N-hydroxy-N-nitrosamines. J. Biol. Chem. 260:4069-74
37. McGill AD, Zhang W, Wittbrodt J, Wang J, Schlegel HB, Wang PG. 2000. para-Substituted N-nitroso-N-oxybenzenamine ammonium salts: a new class of redox-sensitive nitric oxide releasing compounds. Bioorg. Med. Chem. 8:405-12
38. Tang X, Xian M, Trikha M, Honn KV, Wang PG. 2001. Synthesis of peptide-diazeniumdiolate conjugates: towards enzyme activated antitumor agents. Tetrahedron Lett. 42:2625-29
39. Saavedra JE, Keefer LK. 2000. NO better pharmaceuticals. Chem. Br. 36 (No. 7):30-33